Association of obesity with disease outcome in multiple sclerosis.

Lutfullin, Isabel; Eveslage, Maria; Bittner, Stefan; Antony, Gisela; Flaskamp, Martina; Luessi, Felix; Salmen, Anke; Gisevius, Barbara; Klotz, Luisa; Korsukewitz, Catharina; Berthele, Achim; Groppa, Sergiu; Then Bergh, Florian; Wildemann, Brigitte; Bayas, Antonios; Tumani, Hayrettin; Meuth, Sven G; Trebst, Corinna; Zettl, Uwe K; Paul, Friedemann; Heesen, Christoph; Kuempfel, Tania; Gold, Ralf; Hemmer, Bernhard; Zipp, Frauke; Wiendl, Heinz; Lünemann, Jan D

doi:10.1136/jnnp-2022-329685

journal article

Title:: Association of obesity with disease outcome in multiple sclerosis.
Document type:: Article; Journal Article
Author(s):: Lutfullin, Isabel; Eveslage, Maria; Bittner, Stefan; Antony, Gisela; Flaskamp, Martina; Luessi, Felix; Salmen, Anke; Gisevius, Barbara; Klotz, Luisa; Korsukewitz, Catharina; Berthele, Achim; Groppa, Sergiu; Then Bergh, Florian; Wildemann, Brigitte; Bayas, Antonios; Tumani, Hayrettin; Meuth, Sven G; Trebst, Corinna; Zettl, Uwe K; Paul, Friedemann; Heesen, Christoph; Kuempfel, Tania; Gold, Ralf; Hemmer, Bernhard; Zipp, Frauke; Wiendl, Heinz; Lünemann, Jan D
Abstract:: BACKGROUND: Obesity reportedly increases the risk for developing multiple sclerosis (MS), but little is known about its association with disability accumulation. METHODS: This nationwide longitudinal cohort study included 1066 individuals with newly diagnosed MS from the German National MS cohort. Expanded Disability Status Scale (EDSS) scores, relapse rates, MRI findings and choice of immunotherapy were compared at baseline and at years 2, 4 and 6 between obese (body mass index, BMI ≥30 kg/m2) and non-obese (BMI <30 kg/m2) patients and correlated with individual BMI values. RESULTS: Presence of obesity at disease onset was associated with higher disability at baseline and at 2, 4 and 6 years of follow-up (p<0.001). Median time to reach EDSS 3 was 0.99 years for patients with BMI ≥30 kg/m2 and 1.46 years for non-obese patients. Risk to reach EDSS 3 over 6 years was significantly increased in patients with BMI ≥30 kg/m2 compared with patients with BMI <30 kg/m2 after adjustment for sex, age, smoking (HR 1.87; 95% CI 1.3 to 2.6; log-rank test p<0.001) and independent of disease-modifying therapies. Obesity was not significantly associated with higher relapse rates, increased number of contrast-enhancing MRI lesions or higher MRI T2 lesion burden over 6 years of follow-up. CONCLUSIONS: Obesity in newly diagnosed patients with MS is associated with higher disease severity and poorer outcome. Obesity management could improve clinical outcome of MS.
Journal title abbreviation:: J Neurol Neurosurg Psychiatry
Year:: 2023
Journal volume:: 94
Journal issue:: 1
Pages contribution:: 57-61
Fulltext / DOI:: doi:10.1136/jnnp-2022-329685
Pubmed ID:: http://view.ncbi.nlm.nih.gov/pubmed/36319190
Print-ISSN:: 0022-3050
TUM Institution:: 1132; 1527; 1533; 303; Klinik und Poliklinik für Neurologie
BibTeX

Occurrences:

mediaTUM Gesamtbestand Einrichtungen Schools TUM School of Medicine and Health Departments

mediaTUM Gesamtbestand Einrichtungen Schools TUM School of Medicine and Health Departments Clinical Medicine Klinik und Poliklinik für Neurologie (Prof. Hemmer)2023